{"transactions":[{"id":1790825,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2023-09-01T22:00:32.000Z","date":"2023-08-30","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on September 30, 2023."}],"balance_after":8500,"derivative":{"exercise_price":4.655,"expiration_date":"2033-08-30","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001493152-23-031536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315223031536/ownership.xml","form_type":"4"}},{"id":2214644,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2022-07-05T20:05:52.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.255,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-018527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315222018527/ownership.xml","form_type":"4"}},{"id":2561969,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-09-23T00:40:24.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021."}],"balance_after":100000,"derivative":{"exercise_price":1.24,"expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-21-001225","document":"kintara_fm4sep222021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821001225/kintara_fm4sep222021.xml","form_type":"4"}},{"id":2735829,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-04-29T20:05:26.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."}],"balance_after":0,"derivative":{"exercise_date":"2016-04-29","underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0000905718-21-000629","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000629/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2735828,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T20:05:26.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00."}],"balance_after":1566,"source":{"system":"sec-edgar","filing":"0000905718-21-000629","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000629/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2735827,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T20:05:26.000Z","date":"2021-04-29","kind":"other","acquired":true,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1241,"source":{"system":"sec-edgar","filing":"0000905718-21-000629","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000629/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2766366,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-31T20:14:38.000Z","date":"2021-03-31","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1238,"source":{"system":"sec-edgar","filing":"0000905718-21-000505","document":"kintara_fm4mar312021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000505/kintara_fm4mar312021.xml","form_type":"4"}},{"id":2925629,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T13:00:37.000Z","date":"2020-12-31","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1230,"source":{"system":"sec-edgar","filing":"0000899243-21-000043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089924321000043/doc4.xml","form_type":"4"}},{"id":3019856,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-30T20:06:48.000Z","date":"2020-09-30","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1222,"source":{"system":"sec-edgar","filing":"0000905718-20-000999","document":"kintara_fm4sep302020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000999/kintara_fm4sep302020.xml","form_type":"4"}},{"id":3028418,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-09-18T01:03:45.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 15, 2020."}],"balance_after":120000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000905718-20-000965","document":"kintara_fm4sep152020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000965/kintara_fm4sep152020.xml","form_type":"4"}},{"id":3096575,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2020-06-30T20:12:46.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001213900-20-016310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016310/ownership.xml","form_type":"4"}},{"id":3096574,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T20:12:46.000Z","date":"2020-06-30","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1214,"source":{"system":"sec-edgar","filing":"0001213900-20-016310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016310/ownership.xml","form_type":"4"}},{"id":3190857,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T20:18:19.000Z","date":"2020-03-31","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1206,"source":{"system":"sec-edgar","filing":"0001213900-20-008219","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020008219/ownership.xml","form_type":"4"}},{"id":3327133,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:12:23.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1198,"source":{"system":"sec-edgar","filing":"0000905718-20-000014","document":"delmarph_fm4dec312019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000014/delmarph_fm4dec312019.xml","form_type":"4"}},{"id":3403117,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T20:32:42.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1190,"source":{"system":"sec-edgar","filing":"0000905718-19-000817","document":"delmarph_fm4sept302019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000817/delmarph_fm4sept302019.xml","form_type":"4"}},{"id":3419567,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:31:48.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":35433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":35433,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":35433},"source":{"system":"sec-edgar","filing":"0000905718-19-000757","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000757/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419566,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:31:48.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":39567,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0000905718-19-000757","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000757/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3474781,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T20:23:09.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":1182,"source":{"system":"sec-edgar","filing":"0001213900-19-011884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019011884/ownership.xml","form_type":"4"}},{"id":3544354,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2019-05-01T22:33:19.000Z","date":"2019-04-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."}],"balance_after":0,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-007627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019007627/ownership.xml","form_type":"4"}},{"id":3571950,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T20:40:57.000Z","date":"2019-03-29","kind":"other","acquired":true,"shares":74,"price":0.49,"value":36.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11739,"source":{"system":"sec-edgar","filing":"0001213900-19-005509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019005509/ownership.xml","form_type":"4"}},{"id":3713256,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T23:21:35.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":74,"price":0.3419,"value":25.3006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11665,"source":{"system":"sec-edgar","filing":"0001213900-19-000057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019000057/ownership.xml","form_type":"4"}},{"id":3766903,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-11-13T21:38:14.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015513","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018015513/ownership.xml","form_type":"4"}},{"id":3804334,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T20:10:03.000Z","date":"2018-09-28","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11591,"source":{"system":"sec-edgar","filing":"0001213900-18-013299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018013299/ownership.xml","form_type":"4"}},{"id":3875080,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:43:53.000Z","date":"2018-06-29","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11517,"source":{"system":"sec-edgar","filing":"0001213900-18-008716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018008716/ownership.xml","form_type":"4"}},{"id":3973140,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T20:10:06.000Z","date":"2018-03-30","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":11443,"source":{"system":"sec-edgar","filing":"0001213900-18-003993","document":"f4033018toth_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018003993/f4033018toth_delmar.xml","form_type":"4"}},{"id":4112177,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:54:26.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":11369,"source":{"system":"sec-edgar","filing":"0000905718-18-000011","document":"toth_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000011/toth_form4dec312017.xml","form_type":"4"}},{"id":4197769,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T23:48:55.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11295,"source":{"system":"sec-edgar","filing":"0001213900-17-010204","document":"f4092917toth_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017010204/f4092917toth_delmarpharm.xml","form_type":"4"}},{"id":4259074,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2017-07-12T01:37:09.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-17-007480","document":"f4070717toth_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007480/f4070717toth_delmarpharma.xml","form_type":"4"}},{"id":4259073,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2017-07-12T01:37:09.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018."}],"balance_after":36000,"derivative":{"exercise_price":2.11,"exercise_date":"2020-06-30","expiration_date":"2027-07-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-17-007480","document":"f4070717toth_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007480/f4070717toth_delmarpharma.xml","form_type":"4"}},{"id":4264468,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T18:31:47.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11221,"source":{"system":"sec-edgar","filing":"0001213900-17-007151","document":"f4063017toth_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007151/f4063017toth_delmarpharma.xml","form_type":"4"}},{"id":4361273,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T20:39:28.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11147,"source":{"system":"sec-edgar","filing":"0001213900-17-003330","document":"f4033117toth_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017003330/f4033117toth_delmar.xml","form_type":"4"}},{"id":4507880,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T18:53:47.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":11073,"source":{"system":"sec-edgar","filing":"0001213900-17-000019","document":"f4123116toth_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017000019/f4123116toth_delmar.xml","form_type":"4"}},{"id":4584401,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":110032,"kind":"person","name":"TOTH ROBERT JOSEPH JR","position":1,"cik":"0001585020","reported_name":"TOTH ROBERT JOSEPH JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T17:02:21.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":74,"price":3.2,"value":236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":10999,"source":{"system":"sec-edgar","filing":"0001213900-16-017300","document":"f4100316toth_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390016017300/f4100316toth_delmarpharma.xml","form_type":"4"}}]}